186 related articles for article (PubMed ID: 24712331)
1. Diagnosis of early pancreas graft failure via antibody-mediated rejection: single-center experience with 256 pancreas transplantations.
de Kort H; Mallat MJ; van Kooten C; de Heer E; Brand-Schaaf SH; van der Wal AM; Roufosse C; Roelen DL; Bruijn JA; Claas FH; de Fijter JW; Bajema IM
Am J Transplant; 2014 Apr; 14(4):936-42. PubMed ID: 24712331
[TBL] [Abstract][Full Text] [Related]
2. Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.
Niederhaus SV; Leverson GE; Lorentzen DF; Robillard DJ; Sollinger HW; Pirsch JD; Torrealba JR; Odorico JS
Am J Transplant; 2013 Nov; 13(11):2945-55. PubMed ID: 24102905
[TBL] [Abstract][Full Text] [Related]
3. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
[TBL] [Abstract][Full Text] [Related]
4. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
Orandi BJ; Alachkar N; Kraus ES; Naqvi F; Lonze BE; Lees L; Van Arendonk KJ; Wickliffe C; Bagnasco SM; Zachary AA; Segev DL; Montgomery RA
Am J Transplant; 2016 Jan; 16(1):213-20. PubMed ID: 26317487
[TBL] [Abstract][Full Text] [Related]
5. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
6. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
[TBL] [Abstract][Full Text] [Related]
7. De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure.
Mittal S; Page SL; Friend PJ; Sharples EJ; Fuggle SV
Am J Transplant; 2014 Jul; 14(7):1664-71. PubMed ID: 24866735
[TBL] [Abstract][Full Text] [Related]
8. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
[TBL] [Abstract][Full Text] [Related]
9. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
Haas M
Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
[TBL] [Abstract][Full Text] [Related]
10. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
12. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
[TBL] [Abstract][Full Text] [Related]
13. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
14. Pancreas transplantation, antibodies and rejection: where do we stand?
de Kort H; Roufosse C; Bajema IM; Drachenberg CB
Curr Opin Organ Transplant; 2013 Jun; 18(3):337-44. PubMed ID: 23619511
[TBL] [Abstract][Full Text] [Related]
15. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
[TBL] [Abstract][Full Text] [Related]
16. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
17. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
[TBL] [Abstract][Full Text] [Related]
18. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
19. Kidney graft dysfunction in simultaneous pancreas-kidney recipients after pancreas failure: analysis of early and late protocol biopsies.
Viglietti D; Serrato T; Abboud I; Antoine C; Pillebout E; Busson M; Desgrandchamps F; Meria P; Godin M; Hurault de Ligny B; Thervet E; Legendre C; Suberbielle C; Verine J; Glotz D; Peraldi MN
Clin Transplant; 2013; 27(3):E249-55. PubMed ID: 23406495
[TBL] [Abstract][Full Text] [Related]
20. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies.
Kozlowski T; Rubinas T; Nickeleit V; Woosley J; Schmitz J; Collins D; Hayashi P; Passannante A; Andreoni K
Liver Transpl; 2011 Apr; 17(4):357-68. PubMed ID: 21445918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
